Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Texas A&M University Health Science Center College of Medicine, Temple.
JAMA Pediatr. 2020 Jul 1;174(7):705-713. doi: 10.1001/jamapediatrics.2020.0372.
The burden of influenza among young children is high, and influenza vaccination is the primary strategy to prevent the virus and its complications. Less is known about differences in clinical protection following 1 vs 2 doses of initial influenza vaccination.
To describe patterns of influenza vaccination among young children who receive outpatient care for acute respiratory tract illness in the US and compare vaccine effectiveness (VE) against medically attended laboratory-confirmed influenza by number of influenza vaccine doses received.
This test-negative case-control study was conducted in outpatient clinics, including emergency departments, at 5 sites of the US Influenza Vaccine Effectiveness Network during the 2014-2015 through 2017-2018 influenza seasons. The present study was performed from November 5, 2014, to April 12, 2018, during periods of local influenza circulation. Children aged 6 months to 8 years with an acute respiratory tract illness with cough who presented for outpatient care within 7 days of illness onset were included. All children were tested using real-time, reverse-transcriptase polymerase chain reaction for influenza for research purposes.
Vaccination in the enrollment season with either 1 or 2 doses of inactivated influenza vaccine as documented from electronic medical records, including state immunization information systems.
Medically attended acute respiratory tract infection with real-time, reverse-transcriptase polymerase chain reaction testing for influenza.
Of 7533 children, 3480 children (46%) were girls, 4687 children (62%) were non-Hispanic white, and 4871 children (65%) were younger than 5 years. A total of 3912 children (52%) were unvaccinated in the enrollment season, 2924 children (39%) were fully vaccinated, and 697 children (9%) were partially vaccinated. Adjusted VE against any influenza was 51% (95% CI, 44%-57%) among fully vaccinated children and 41% (95% CI, 25%-54%) among partially vaccinated children. Among 1519 vaccine-naive children aged 6 months to 2 years, the VE of 2 doses in the enrollment season was 53% (95% CI, 28%-70%), and the VE of 1 dose was 23% (95% CI, -11% to 47%); those who received 2 doses were less likely to test positive for influenza compared with children who received only 1 dose (adjusted odds ratio, 0.57; 95% CI, 0.35-0.93).
Consistent with US influenza vaccine policy, receipt of the recommended number of doses resulted in higher VE than partial vaccination in 4 influenza seasons. Efforts to improve 2-dose coverage for previously unvaccinated children may reduce the burden of influenza in this population.
儿童患流感的负担很高,而流感疫苗接种是预防病毒及其并发症的主要策略。对于初次接种流感疫苗后,1 剂与 2 剂之间的临床保护效果差异,我们了解得较少。
描述在美国因急性呼吸道疾病接受门诊治疗的幼儿中流感疫苗接种的模式,并根据接受的流感疫苗剂量数比较针对经医学证实的流感的疫苗有效性(VE)。
本项测试阴性病例对照研究在美国流感疫苗有效性网络的 5 个地点的门诊诊所(包括急诊科)中进行,在 2014-2015 至 2017-2018 流感季节进行。本研究于 2014 年 11 月 5 日至 2018 年 4 月 12 日进行,在此期间当地有流感传播。研究纳入了在疾病发病后 7 天内因急性呼吸道疾病伴咳嗽而接受门诊治疗的 6 个月至 8 岁儿童。所有儿童均使用实时、逆转录酶聚合酶链反应进行了针对流感的研究目的检测。
在入组季节,根据电子病历(包括州免疫信息系统)记录,接种了 1 剂或 2 剂灭活流感疫苗。
采用实时、逆转录酶聚合酶链反应检测的经医学证实的急性呼吸道感染。
在 7533 名儿童中,3480 名儿童(46%)为女孩,4687 名儿童(62%)为非西班牙裔白人,4871 名儿童(65%)年龄小于 5 岁。共有 3912 名儿童(52%)在入组季节未接种疫苗,2924 名儿童(39%)完全接种了疫苗,697 名儿童(9%)部分接种了疫苗。完全接种疫苗的儿童中针对任何流感的 VE 为 51%(95%CI,44%-57%),部分接种疫苗的儿童中 VE 为 41%(95%CI,25%-54%)。在 1519 名 6 个月至 2 岁的疫苗初免儿童中,入组季节接种 2 剂的 VE 为 53%(95%CI,28%-70%),接种 1 剂的 VE 为 23%(95%CI,-11%至 47%);与仅接种 1 剂的儿童相比,接种 2 剂的儿童更不可能检测出流感阳性(调整后比值比,0.57;95%CI,0.35-0.93)。
与美国流感疫苗接种政策一致,在 4 个流感季节中,推荐剂量的接种效果优于部分接种。努力提高以往未接种疫苗儿童的 2 剂覆盖率可能会降低该人群的流感负担。